Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis

Koleshwar Mahto, Omkar Kumar Kuwar, Aayushi Maloo, Nileshwar Kalia

Open source

DOI
10.1007/s10787-025-01846-3
Published
2025-07-22
Container
Inflammopharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10787-025-01846-3,
  title = {Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis},
  author = {Koleshwar Mahto and Omkar Kumar Kuwar and Aayushi Maloo and Nileshwar Kalia},
  year = {2025},
  journal = {Inflammopharmacology},
  doi = {10.1007/s10787-025-01846-3},
  url = {https://doi.org/10.1007/s10787-025-01846-3}
}

RIS

TY  - JOUR
TI  - Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis
AU  - Koleshwar Mahto
AU  - Omkar Kumar Kuwar
AU  - Aayushi Maloo
AU  - Nileshwar Kalia
PY  - 2025
JO  - Inflammopharmacology
DO  - 10.1007/s10787-025-01846-3
UR  - https://doi.org/10.1007/s10787-025-01846-3
ER  - 

APA

Mahto, K., Kuwar, O. K., Maloo, A., & Kalia, N. (2025). Therapeutic potential of luteolin in neurodegenerative disorders: targeting Nrf2, NFĸB, MAPK, and JAK-STAT pathways to combat neuroinflammation and apoptosis. Inflammopharmacology. https://doi.org/10.1007/s10787-025-01846-3

Source records